Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 205583 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DESVENLAFAXINE FUMARATE MONOHYDRATE(UNII: R5JHD7L72A) (DESVENLAFAXINE - UNII:NG99554ANW) | DESVENLAFAXINE | 100mg | 50mg |
Inactive Ingredients
| Ingredient Name | Sun Pharma Global FZE |
|---|---|
| AMMONIA(5138Q19F1X) | |
| BUTYL ALCOHOL(8PJ61P6TS3) | |
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| HYPROMELLOSES(3NXW29V3WO) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SHELLAC(46N107B71O) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
